Alphabet Inc.
Sector Allocation
- Technology97.3%$96.5B
- Healthcare0.9%$899.3M
- Financials0.8%$835.1M
- Communication Services0.8%$794.7M
- Utilities0.1%$51.5M
- Industrials0.1%$44.8M
AUM History
13fpro.ai/research/fund/alphabet-inc-1652044
Conviction and streaks
Concentrating · top 10 = 99.5%From the fund's last 12 quarters of 13F filings: positions held longest at size, and names it added to or trimmed several quarters running.
Largest positions — Q2 2026
SPCX
$94.2BPL
$1.2BASTS
$794.7MCME
$769.4MARM
$695.2MRVMD
$551.8MFRSH
$164.0MPBLS
$134.6MTEM
$89.9MGTLB
$83.2MPATH
$76.5MLIFE
$65.7MPRME
$61.1MFRVO
$51.5MPAYP
$44.8MMAZE
$41.4MRLAY
$26.4MBBOT
$21.5MOSCR
$13.7MBEAM
$11.0M
Top 20 stock positions. Options are left out: 13F reports them at the underlying's value.
13fpro.ai/research/fund/alphabet-inc-1652044
Alphabet Inc. 13F holdings — Q2 2026
$99.1B portfolio · 28 holdings · Q2 2026 13F · top 10 are 100% of the stock portfolio
$94.2B
95.0% of stocks
NewThis quarter+10.4%Since filedNew this quarterHeld$1.2B
1.2% of stocks
No changeThis quarter-42.5%Since filed9+ qtrsHeld$794.7M
0.8% of stocks
No changeThis quarter-45.2%Since filed6 qtrsHeld$769.4M
0.8% of stocks
No changeThis quarter+16.8%Since filed2 qtrsHeld$695.2M
0.7% of stocks
No changeThis quarter-21.0%Since filed9+ qtrsHeld$551.8M
0.6% of stocks
-11%This quarter-10.4%Since filed9+ qtrsHeldAIQualityAI quality score is Pro: unlock with a free trialEst. buyEstimated buy price is Pro: unlock with a free trialTrimmed 3 qtrs in a row$164.0M
0.2% of stocks
No changeThis quarter+29.7%Since filed9+ qtrsHeld$134.6M
0.1% of stocks
NewThis quarter-28.4%Since filedNew this quarterHeld$89.9M
0.1% of stocks
No changeThis quarter+29.0%Since filed9+ qtrsHeld$83.2M
0.1% of stocks
No changeThis quarter+45.4%Since filed9+ qtrsHeld
All holdings — Alphabet Inc. (Q2 2026)
28 disclosed positions from the Form 13F-HR on SEC EDGAR, with quarter-over-quarter share changes. Largest by value first; the ten above are not repeated.
| # | Company | Held | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 11 | UiPath, Inc. | Technology | $76.5M | 0.1% | 7.03M | — | 9+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 12 | Ethos Technologies Inc. | Financials | $65.7M | 0.1% | 3.62M | -4% | 2 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 13 | Prime Medicine, Inc. | Healthcare | $61.1M | 0.1% | 16.56M | — | 9+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 14 | Fervo Energy Co | Utilities | $51.5M | 0.1% | 1.76M | New | 1 qtr | AI quality score is Pro: unlock with a free trial | 13F | |
| 15 | PayPay Corpadr | Industrials | $44.8M | 0.1% | 3.13M | — | 2 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 16 | Maze Therapeutics, Inc. | Healthcare | $41.4M | 0.0% | 1.39M | — | 6 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 17 | Relay Therapeutics, Inc. | Healthcare | $26.4M | 0.0% | 1.41M | -10% | 9+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 18 | BridgeBio Oncology Therapeutics, Inc. | Healthcare | $21.5M | 0.0% | 2.82M | — | 4 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 19 | Oscar Health, Inc. | Healthcare | $13.7M | 0.0% | 482K | — | 9+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 20 | Beam Therapeutics Inc. | Healthcare | $11.0M | 0.0% | 322K | — | 9+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 21 | Vera Therapeutics, Inc. | Healthcare | $10.4M | 0.0% | 241K | — | 9+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 22 | Sana Biotechnology, Inc. | Healthcare | $9.8M | 0.0% | 2.81M | — | 9+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 23 | Monte Rosa Therapeutics, Inc. | Healthcare | $9.0M | 0.0% | 372K | -46% | 9+ qtrsTrimmed 3 qtrs in a row | AI quality score is Pro: unlock with a free trial | 13F | |
| 24 | Lyell Immunopharma, Inc. | Healthcare | $4.1M | 0.0% | 293K | — | 9+ qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 25 | Figma, Inc. | Technology | $3.9M | 0.0% | 216K | — | 4 qtrs | AI quality score is Pro: unlock with a free trial | 13F | |
| 26 | $SPRO | Spero Therapeutics, Inc. | Healthcare | $2.0M | 0.0% | 890K | — | |||
| 27 | $HYPR | Hyperfine, Inc. | Healthcare | $1.2M | 0.0% | 899K | — | |||
| 28 | $AUTL | Autolus Therapeutics plc | Healthcare | $1.1M | 0.0% | 698K | — |
What changed in Q2 2026
Against the previous quarter's 13F: 3 new, 0 added to, 4 trimmed, 1 sold out. Share-count changes; largest moves by dollar size first.
New positions (3)
Added to (0)
No positions added to this quarter.
Trimmed (4)
Sold out (1)
$TNYATenaya Therapeutics, Inc.was $632K
held 9+ qtrs
Holdings by quarter
Every 13F Alphabet Inc. has filed, 41 earlier quarters. Pick one to see what it held then.
Is it too late to follow Alphabet?
Q2 2026 13F filed with the SEC on Aug 7, 2026. Prices are closing prices as of Oct 26, 2026.
Average quality of Alphabet's top 20 holdings: 45/100 (our AI quality score, weighted by position size; 13 of the 20 are scored)
Top 10 since filing
+9.0%
Value-weighted move of the 10 largest stock positions
Turnover
—
Last quarter
Top 10 weight
100%
Share of the stock portfolio in its 10 largest positions
Held 4+ quarters
4%
Share of portfolio value in positions held a year or more
Highest-quality names it owns(among its 100 largest positions)
The 8 highest-scoring companies in this portfolio are a Pro feature.
How these are measured
- Moves since the quarter-end and since the filing date use our own daily closing prices, from the close on (or just before) each date to the latest close.
- Turnover is the lesser of shares bought or sold in a quarter, valued at the quarter-end prices in the 13F, divided by the average of the two quarters' stock portfolio values.
- Quarters held and add/trim streaks count back only through quarters whose filed holdings add up to the filing's own cover-page total (back to Q2 2024 for this fund). A change counts as an add or a trim when the split-adjusted share count moves by more than 1%.
- Estimate, not the fund's reported cost. For each quarter in the current holding period in which the fund's share count rose (split-adjusted), we take that quarter's average daily close and weight it by the shares added; sales do not change an average cost. Quarters where the stock's price history and the 13F's own implied price disagree by more than 2x are left out.
- Put and call option rows report the value of the underlying shares, not a position the fund paid for, so they are left out of all of the above.
Portfolio Overview
Alphabet Inc. disclosed 28 positions worth $99.1B in its Form 13F-HR for Q2 2026, led by $SPCX (SPACE EXPLORATION TECHNOLOGIES CORP) at 95.0% of the equity portfolio, followed by $PL and $ASTS. During the quarter the fund opened 3 new positions and exited 1 — including a new stake in $SPCX and a full exit from $TNYA. The portfolio is most concentrated in Technology (97.3% of disclosed assets). All figures are sourced directly from Alphabet Inc.’s Form 13F-HR filing with the SEC under CIK 1652044.
Funds like this
managers whose biggest positions overlap Alphabet'sBrowse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
AI-Powered Hedge Fund Analysis: Alphabet Inc.
13F Pro is an AI hedge fund tracker and stock research platform. For Alphabet Inc. (SEC CIK: 1652044), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in Alphabet Inc.'s portfolio is scored on an AI quality ranking built from its SEC filings (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.